• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jclinpathJournal of Clinical PathologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Clin Pathol. Nov 1994; 47(11): 1035–1037.
PMCID: PMC503069

Serum placental-type alkaline phosphatase activity in women with squamous and glandular malignancies of the reproductive tract.

Abstract

AIM--To investigate serum placental-type alkaline phosphatase (PLAP-type) activities in women with squamous and glandular malignancies of the reproductive tract using an immunoradiometric assay. METHODS--PLAP-type immunoreactivity was measured in 180 women with non-ovarian malignancies of the reproductive tract and the values were compared with those from 334 controls. The cases comprised 18 vulval, nine vaginal, 103 cervical, 46 endometrial, and five fallopian tube cancers. RESULTS--Serum PLAP-type activities were no different from controls in patients with squamous cell tumours. Women with adenocarcinoma of the cervix, endometrium, and fallopian tube had increased values: women with endometrial cancer had a median value nearly four times greater than that of controls. There was no direct correlation between PLAP-type activities and stage of disease in patients with endometrial cancer, but values reverted to normal after treatment. CONCLUSIONS--Serum PLAP-type measurements are of no value in the management of patients with squamous cell tumours of the female reproductive tract. Raised activities can, however, be found in glandular tumours, in particular endometrial cancer where serum PLAP-type measurements may be of value in predicting remission.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (604K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Fishman WH, Inglis NR, Vaitukaitis J, Stolbach LL. Regan isoenzyme and human chorionic gonadotropin in ovarian cancer. Natl Cancer Inst Monogr. 1975 Oct;42:63–73. [PubMed]
  • Nouwen EJ, Pollet DE, Schelstraete JB, Eerdekens MW, Hänsch C, Van de Voorde A, De Broe ME. Human placental alkaline phosphatase in benign and malignant ovarian neoplasia. Cancer Res. 1985 Feb;45(2):892–902. [PubMed]
  • Lange PH, Millan JL, Stigbrand T, Vessella RL, Ruoslahti E, Fishman WH. Placental alkaline phosphatase as a tumor marker for seminoma. Cancer Res. 1982 Aug;42(8):3244–3247. [PubMed]
  • McDicken IW, McLaughlin PJ, Tromans PM, Luesley DM, Johnson PM. Detection of placental-type alkaline phosphatase in ovarian cancer. Br J Cancer. 1985 Jul;52(1):59–64. [PMC free article] [PubMed]
  • Horwich A, Tucker DF, Peckham MJ. Placental alkaline phosphatase as a tumour marker in seminoma using the H17 E2 monoclonal antibody assay. Br J Cancer. 1985 May;51(5):625–629. [PMC free article] [PubMed]
  • Tucker DF, Oliver RT, Travers P, Bodmer WF. Serum marker potential of placental alkaline phosphatase-like activity in testicular germ cell tumours evaluated by H17E2 monoclonal antibody assay. Br J Cancer. 1985 May;51(5):631–639. [PMC free article] [PubMed]
  • Iles RK, Ind TE, Chard T. Production of placental alkaline phosphatase (PLAP) and PLAP-like material by epithelial germ cell and non-germ cell tumours in vitro. Br J Cancer. 1994 Feb;69(2):274–278. [PMC free article] [PubMed]
  • Chatzaki E, Gallagher CJ, Iles RK, Ind TE, Nouri AM, Bax CM, Grudzinskas JG. Characterisation of the differential expression of marker antigens by normal and malignant endometrial epithelium. Br J Cancer. 1994 Jun;69(6):1010–1014. [PMC free article] [PubMed]
  • Benham F, Cottell DC, Franks LM, Wilson PD. Alkaline phosphatase activity in human bladder tumor cell lines. J Histochem Cytochem. 1977 Apr;25(4):266–274. [PubMed]
  • De Broe ME, Pollet DE. Multicenter evaluation of human placental alkaline phosphatase as a possible tumor-associated antigen in serum. Clin Chem. 1988 Oct;34(10):1995–1999. [PubMed]
  • Kellen JA, Bush RS, Malkin A. Placenta-like alkaline phosphatase in gynecological cancers. Cancer Res. 1976 Jan;36(1):269–271. [PubMed]
  • McLaughlin PJ, Gee H, Johnson PM. Placental-type alkaline phosphatase in pregnancy and malignancy plasma: specific estimation using a monoclonal antibody in a solid phase enzyme immunoassay. Clin Chim Acta. 1983 May 30;130(2):199–209. [PubMed]
  • Nozawa S, Udagawa Y, Ohkura H, Negishi Y, Akiya K, Inaba N, Takamizawa H, Kimura E, Terashima Y. Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies--with special reference to the combination of PLAP and CA54/61 assay. Clin Chim Acta. 1990 Jan 15;186(2):275–284. [PubMed]
  • Tholander B, Taube A, Lindgren A, Sjöberg O, Stendahl U, Tamsen L. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease. Gynecol Oncol. 1990 Oct;39(1):26–33. [PubMed]
  • Vergote I, Onsrud M, Nustad K. Placental alkaline phosphatase as a tumor marker in ovarian cancer. Obstet Gynecol. 1987 Feb;69(2):228–232. [PubMed]
  • Hoylaerts MF, Manes T, Millán JL. Molecular mechanism of uncompetitive inhibition of human placental and germ-cell alkaline phosphatase. Biochem J. 1992 Aug 15;286(Pt 1):23–30. [PMC free article] [PubMed]
  • Ind TE, Iles RK, Chard T. Low serum levels of placental and placental-like alkaline phosphatase isoenzymes in women with blood groups A and AB. Ann Clin Biochem. 1994 Jan;31(Pt 1):89–90. [PubMed]
  • McLaughlin PJ, Twist AM, Evans CC, Johnson PM. Serum placental type alkaline phosphatase in cigarette smokers. J Clin Pathol. 1984 Jul;37(7):826–828. [PMC free article] [PubMed]
  • Maslow WC, Muensch HA, Azama F, Schneider AS. Sensitive fluorometry of heat-stable alkaline phosphatase (Regan enzyme) activity in serum from smokers and nonsmokers. Clin Chem. 1983 Feb;29(2):260–263. [PubMed]
  • Muensch HA, Maslow WC, Azama F, Bertrand M, Dewhurst P, Hartman B. Placental-like alkaline phosphatase. Re-evaluation of the tumor marker with exclusion of smokers. Cancer. 1986 Oct 15;58(8):1689–1694. [PubMed]
  • Tonik SE, Ortmeyer AE, Shindelman JE, Sussman HH. Elevation of serum placental alkaline phosphatase levels in cigarette smokers. Int J Cancer. 1983 Jan 15;31(1):51–53. [PubMed]
  • Ind TE, Iles RK, Wathen NC, Murugan P, Campbell J, Macintosh M, Chard T. Low levels of amniotic fluid placental alkaline phosphatase in Down's syndrome. Br J Obstet Gynaecol. 1993 Sep;100(9):847–849. [PubMed]
  • Fishman WH, Inglis NR, Green S, Anstiss CL, Gosh NK, Reif AE, Rustigian R, Krant MJ, Stolbach LL. Immunology and biochemistry of Regan isoenzyme of alkaline phosphatase in human cancer. Nature. 1968 Aug 17;219(5155):697–699. [PubMed]
  • Doellgast GJ, Homesley HD. Placental-type alkaline phosphatase in ovarian cancer fluids and tissues. Obstet Gynecol. 1984 Mar;63(3):324–329. [PubMed]
  • Cadeau BJ, Blackstein ME, Malkin A. Increased incidence of placenta-like alkaline phosphatase activity in breast and genitourinary cancer. Cancer Res. 1974 Apr;34(4):729–732. [PubMed]
  • Davies JO, Davies ER, Howe K, Jackson P, Pitcher E, Randle B, Sadowski C, Stirrat GM, Sunderland CA. Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer. J R Soc Med. 1985 Nov;78(11):899–905. [PMC free article] [PubMed]
  • Mano H, Furuhashi Y, Morikawa Y, Hattori SE, Goto S, Tomoda Y. Radioimmunoassay of placental alkaline phosphatase in ovarian cancer sera and tissues. Obstet Gynecol. 1986 Dec;68(6):759–764. [PubMed]
  • Fisken J, Leonard RC, Shaw G, Bowman A, Roulston JE. Serum placental-like alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer. J Clin Pathol. 1989 Jan;42(1):40–45. [PMC free article] [PubMed]
  • Haije WG, van Driel J, van der Burg ME. Catalytic and immunologic activities of placental-like alkaline phosphatase in clinical studies. The value of PLAP in follow-up of ovarian cancer. Clin Chim Acta. 1987 Jun 15;165(2-3):165–175. [PubMed]
  • Vergote IB, Abeler VM, Børmer OP, Stigbrand T, Tropé C, Nustad K. CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma. Tumour Biol. 1992;13(3):168–174. [PubMed]
  • Kenemans P, Yedema CA, Hilgers JH, Massuger LF, Verheijen RH, Thomas CM, Poels LG. Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens. Eur J Obstet Gynecol Reprod Biol. 1988 Nov;29(3):207–218. [PubMed]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...